Pharma and Biotech Research News New York

Pharma, Biopharma & Biotech News

Mar 4

Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer

Prana Thoracic is developing the first minimally invasive, lung-sparing device for early intervention of suspicious pulmonary nodules.

Mar 2

Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

RADICAVA is administered in 28-day cycles by IV infusion for ALS.

Feb 24

Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million

. While various psychedelics have demonstrated promise for the treatment of PTSD, Transcend focuses on a psychoactive compound that may...

Feb 22

Rare and orphan disease focused Quoin Pharmaceuticals (Nasdaq: QNRX) prices $7 million placement

Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products

Feb 17

LifeArc Ventures participates in a $16 million financing for Maxion Therapeutics for antibody drugs

The funds will be used for the development of novel biologics targeting ion channels and G-procoupled receptors

Feb 15

Great Product Ventures initiates strategic relationship with life sciences regulatory services firm

Great Product Ventures is a venture development firm whose mission is to identify the top European Companies to commercialize and fund...

Feb 14

Nasdaq-listed SeqLL prices $1.8 million offering

The gross proceeds to the Company from the Offering are estimated to be approximately $1.8 million.

Feb 13

Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services

Feb 1

Panbela prices $15 million public offering

CPP-1X (eflornithine) is being developed as a single agent tablet or high dose power sachet for several indications including prevention...

Jan 18

To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab

The company seeks to achieve U.S. regulatory approval for Bentracimab within the first-half of 2024.

Jan 10

Trinity Biotech partners with imaware to deliver diagnostic testing solutions for digital health

imaware’s mission is to empower the health of humanity by providing testing and technology solutions for healing at scale.

Jan 7

Retinal Degeneration Fund participates in a $78 million funding round for Perceive Biotherapeutics

AMD is the leading cause of blindness in people 55 and older, affecting more than 150 million people worldwide and 10 million people in US

Jan 4

Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

Enrollment for the clinical trials is expected to begin in the second quarter of 2023

Jan 3

Biocytogen and Hansoh Pharma Enter Into An Antibody License Agreement

Project Integrum is a large-scale antibody drug development project for 1000+ potential drug targets

Dec 27, 2022

Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies

Under the agreement. Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze...

Dec 11, 2022

iBio, an AI-driven innovator of precision antibody immunotherapies, closes $3.5 million financing

iBio’s mission is to decrease drug failures, shorten drug development timelines, and open up new frontiers against the most promising...

Dec 9, 2022

OMNY Health Closes $17 Million to Lead the Next Generation of Real-World Data-Driven Decision-Making

sahi Kasei, is publicly calling for new proposals for drug development research as part of its efforts for open innovation to promote..

Nov 29, 2022

MIT: New CRISPR-based tool inserts large DNA sequences at desired sites in cells

The researchers are now further exploring the possibility of using this tool as a possible way to replace the defective cystic fibrosis gene

Nov 23, 2022

scPharmaceuticals Announces Pricing of $50 Million Public Offering

scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential...

Nov 5, 2022

H.I.G. Capital acquires leading global clinical research organization Celerion

Headquartered in Lincoln, NE, Celerion is a leading global clinical research organization focused on providing end-to-end early stage clinic

Nov 2, 2022

J.P. Morgan Launches New Life Sciences Private Capital Team to Invest in Healthcare Companies

"Our new Life Sciences Private Capital team combines some of the industry's most revered biotech investors, operators and founders..."

Oct 28, 2022

Biotech Fund launched with $100 Million of Assets to Focus on Better Drugs, Devices and Diagnostics

Its initial investments include Neuralink, Elon Musk’s brain-computer interface start-up, and Kling Biotherapeutics.

Oct 24, 2022

Biotechs, Developing Countries, Vaccine Manufacturers and Pharma Unite for Better Vaccine Access

The proposal offers to reserve a real-time allocation of vaccines production for vulnerable populations in lower-income countries.

Oct 15, 2022

Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development

The company is focused on innovative targeted radiopharmaceuticals for the diagnosis, monitoring, and therapy of cancer.

Oct 8, 2022

RadioMedix raises $40 million to advance its alpha therapy platform for oncology

Targeted alpha therapies are currently considered one of the most advanced technologies available to treat patients with incurable cancers.

Oct 4, 2022

Eagle Pharmaceuticals and Enalare Therapeutics receive FDA Orphan Drug designation

Currently, pharmacologic treatment for these neonates is typically limited to caffeine or other methylxanthines.

Oct 2, 2022

CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

“EpiSmart has the potential to be a game-changer for the treatment for keratoconus.

Sep 28, 2022

Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

Aqualung is an early-stage biotech company developing immune-focused therapeutic platform, eNamptor™.

Sep 27, 2022

SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects

Our team is addressing two core issues with our proprietary technology: enhancing bioavailability and reducing development time.

Sep 3, 2022

Early-stage novel cell therapy company Neukio Biotherapeutics closes a $50 million financing

The transition from traditional small molecules and antibodies to the era of cell therapy is a great leap in drug design and manufacturing

Sep 1, 2022

OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) is a life sciences and biotechnology company recently listed on Nasdaq .

Aug 20, 2022

Laos-based pharmaceutical company BioSpring completes phase 1 of manufacturing facility

BioSpring is a vertically integrated pharmaceutical company providing solutions from formulation development to product commercialization.

Aug 13, 2022

Clario invests in new technology to reduce translation times for clinical trials

For nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials.

Aug 5, 2022

Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

Immunis’ FDA Phase 1/2a clinical trial is a study to assess IMM01-STEM in elderly participants with muscle atrophy.

Aug 3, 2022

IDRx raises $122 million to transform cancer treatment with precision combination therapies

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies.

Jul 30, 2022

Ozette closes on $26 million to advance its AI-Powered Single-Cell Immune Discovery Technology

The new funding will fuel company growth and enable Ozette to expand its capabilities across a multiomic platform

Jul 27, 2022

PCI Pharma Services to expand it’s UK manufacturing capability for manufacturing oncology treatments

The expansion includes two new facilities dedicated to the manufacturing and packaging of solid oral-dose tablets and capsules.

Jul 15, 2022

Manifold Bio Raises $40 Million for its next-generation protein engineering platform

Manifold Bio is a fully-integrated biotechnology company pursuing a pipeline of targeting-enhanced protein therapeutics.

Jul 9, 2022

Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology

There’s a major unmet need to improve outcomes for cancer patients and Kernal Bio has built a strong rational for the use of its novel mRNA

Jul 5, 2022

Mindset Pharma develops an intranasal platform for psychedelic medicines

Mindset Pharma is focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological disorders.

Jul 1, 2022

Twist Bioscience and Ildong Pharmaceutical Collaborate on Antibody Discovery for Immuno-oncology

Under the terms of the agreement, Ildong will license a suite of Twist’s VHH libraries for a period of three years.

Jun 24, 2022

Eton Pharmaceuticals sells its hospital products to Dr. Reddy’s Laboratories for $50 million

Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

Jun 23, 2022

A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics

A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company.

Jun 12, 2022

Degron Therapeutics Raises $22 Million for its Molecular-Glue-Based Targeted Protein Degradation

The company’s pipeline includes a growing number of preclinical compounds for oncology, inflammation, metabolic disease, and rare diseases.

Jun 8, 2022

L7 Informatics Raises $38 Million to Accelerate Innovation in Precision Healthcare

Over the last decade, personalized healthcare has spread beyond oncology and now comprises almost half of all new drugs in development.

Jun 7, 2022

OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA

OriCiro Genomics’ unique cell-free DNA technology has a tremendous potential for business applications, particularly for healthcare.

Jun 5, 2022

Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials

Imaging Endpoints is the world’s largest oncology-focused imaging CRO and has partnered with ImaginAb over the past decade.

Jun 4, 2022

GE Healthcare will help advance cancer care and advance the practice of precision medicine

Precision imaging is fundamental to determining the size, shape and characteristics of tumors and differentiating between healthy tissues.

May 29, 2022

KDx Diagnostics and UroGPO partner to offer the URO17 non-invasive urine test for bladder cancer

URO17 is a non-invasive urine test with high sensitivity and negative predicted value (NPV) to determine the status of active bladder cancer

May 27, 2022

Parallel Learning closes on $20 million to test, diagnose and empower special needs students

Our mission is to work hand-in-hand with school districts and families to deliver the highest quality developmental services.